Vontobel Holding’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
Other funds holding PTCT
RI
AC
Vontobel Holding's PTCT Position: Q4 2025 in Review
Vontobel Holding sold out of PTC Therapeutics (PTCT) in Q4 2025, closing a stake of 7,620 shares — an estimated $468K sold.
Vontobel Holding first reported a position in PTCT in Q4 2020 and held it in 12 quarters. The position peaked at $1.78M in Q3 2022. 353 funds tracked by Wall St. Rank hold PTCT as of Q4 2025.
- Vontobel Holding reported no remaining PTC Therapeutics position as of Q4 2025 after selling out during the quarter.
- Vontobel Holding sold 7,620 PTC Therapeutics shares in Q4 2025, an estimated $468K.
- Vontobel Holding first reported a position in PTC Therapeutics in Q4 2020 and held it in 12 quarters.
- Vontobel Holding's PTC Therapeutics position peaked at $1.78M in Q3 2022.
- 353 funds tracked by Wall St. Rank held PTC Therapeutics as of Q4 2025.
Based on Vontobel Holding's 13F filing for Q4 2025, filed 13 Feb 2026.